Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001641172-25-005057
Filing Date
2025-04-16
Accepted
2025-04-16 16:30:42
Documents
5

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 192581
2 ex5-1.htm EX-5.1 16247
3 ex23-1.htm EX-23.1 3991
4 ex107.htm EX-FILING FEES 31788
5 ex5-1_001.jpg GRAPHIC 25724
  Complete submission text file 0001641172-25-005057.txt   281502
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (617) 798-6700
Ernexa Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-286581 | Film No.: 25843184
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)